Cargando…

First-generation vs second-generation antipsychotic drugs: The ongoing saga

Detalles Bibliográficos
Autor principal:	Gupta, Sumeet
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824991/ https://www.ncbi.nlm.nih.gov/pubmed/20174527 http://dx.doi.org/10.4103/0019-5545.58904

Ejemplares similares

Obesity and Insulin Resistance: An Ongoing Saga
por: Kim, Sun H., et al.
Publicado: (2010)

Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2021)

Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
por: Still, Daniel, et al.
Publicado: (2023)

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis
por: Ansell, B. R. E., et al.
Publicado: (2015)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

Response to “The untold saga of chromotherapy in dentistry”
por: Wheeler, Thomas J.
Publicado: (2023)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Response to comment on the recently published article “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
por: VandenBerg, Amy M.
Publicado: (2023)

The saga of an anesthesiologist: frontline COVID-19 warrior
por: Syal, Rashmi, et al.
Publicado: (2020)

The COVID-19 Vaccine Saga: A Perspective
por: Patil, Shashank M, et al.
Publicado: (2021)

The heated debate over NAFLD renaming: An ongoing saga
por: Yilmaz, Yusuf
Publicado: (2023)

Blood lactate levels in patients receiving first- or second- generation antipsychotics
por: Glavina, Trpimir, et al.
Publicado: (2011)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database
por: Fife, Daniel, et al.
Publicado: (2021)

Comparison of hospitalizations in patients on first generation versus second generation long acting injectable (LAI) antipsychotics
por: Rasool, Seemab, et al.
Publicado: (2021)

Attitudes Towards Antipsychotics Among Patients with Schizophrenia on First- or Second-Generation Medications
por: Karthik, M. S., et al.
Publicado: (2014)

Influence of first- and second-generation antipsychotics on anthropometric parameters of male psychiatric patients
por: Nkondo-Ndaba, Maseqhala P., et al.
Publicado: (2022)

Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium
por: Vázquez, Gustavo H., et al.
Publicado: (2021)

Ongoing tuberculosis transmission among second-generation Ethiopian immigrants
por: Bishara, H., et al.
Publicado: (2020)

Arterial Stiffness in Patients Taking Second-generation Antipsychotics
por: Fındıklı, Ebru, et al.
Publicado: (2016)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

First-generation antipsychotics: not gone but forgotten
por: Dibben, Claire R. M., et al.
Publicado: (2016)

The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study
por: Bodnar, Michael, et al.
Publicado: (2016)

Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
por: Alevizopoulos, Georgios, et al.
Publicado: (2021)

Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics
por: Gautam, Shiv, et al.
Publicado: (2011)

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008)

Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics
por: Oh, Jee-Eun, et al.
Publicado: (2012)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Overcoming barriers to monitoring patients taking second-generation antipsychotics
por: Peña, Anita, et al.
Publicado: (2018)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Combination treatment with second generation antipsychotics other than clozapine
por: Schmidt-Kraepelin, C.
Publicado: (2021)

Risk of Breast Cancer in Association with the Use of Second-generation Antipsychotics
por: Joo, Sung Woo, et al.
Publicado: (2022)

Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis
por: Ramachandran, Sujith, et al.
Publicado: (2016)

Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
por: Berle, Jan Øystein, et al.
Publicado: (2013)

Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
por: Moschny, Nicole, et al.
Publicado: (2021)

Comparison of Biotin Interference in Second- and Third-Generation Roche Free Thyroxine Immunoassays
por: Choi, Jungim, et al.
Publicado: (2020)

Retraction: Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report
por: Berle, Jan Øystein, et al.
Publicado: (2013)

Noninvasive ventilation duration as an outcome predictor in acute exacerbation of COPD and respiratory failure: The saga continues
por: Karim, Habib Md Reazaul, et al.
Publicado: (2021)

A retrospective study of extrapyramidal syndromes with second generation antipsychotics in the psychiatric unit of a tertiary care teaching hospital
por: Lahon, Kingshuk, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m6rjudp0vss1v8sa3485kvpc24